Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

32.28
+1.023.25%
Post-market: 32.500.2250+0.70%19:30 EDT
Volume:1.29M
Turnover:41.54M
Market Cap:2.31B
PE:-5.47
High:32.97
Open:31.42
Low:31.03
Close:31.26
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:0.52
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.68
PE(LYR):-6.92

Loading ...

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 18

Vera Therapeutics Price Target Maintained with a $34.00/Share by Wedbush

Dow Jones
·
Aug 17

Vera Rises on Early Kidney Function Data in FDA Review

Reuters
·
Aug 15

Analyst Maintains Buy on Vera Therapeutics, Cutting Trutakna Price Target to $90 Amid Rising IgAN Competition

TIPRANKS
·
Aug 12

Analyst Sees Vera Well Positioned for Trutakna IgAN Launch, Sustained Uptake and Long‑Term Value Creation

TIPRANKS
·
Aug 12

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 11

Vera Therapeutics Price Target Cut to $34.00/Share from $43.00 by Wedbush

Dow Jones
·
Aug 11

Vera Therapeutics, Inc. : Wedbush Cuts Target Price to $34 from $43

THOMSON REUTERS
·
Aug 11

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $43, Maintains Neutral Rating

MT Newswires Live
·
Aug 11

Vera Therapeutics (VERA) Gets a Buy from Bank of America Securities

TIPRANKS
·
Aug 11

Vera Therapeutics Q2 Loss Widens Less than Expected

Reuters
·
Aug 11

Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) Estimate

Benzinga Earnings
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Vera Therapeutics Q2 FY26 Net Loss Widens to $109.5 Million; Loss Per Share Rises to $1.52

Reuters
·
Aug 11

Vera Therapeutics, - Anticipates Sbla Submission to FDA for Trutakna in Q4 2026

THOMSON REUTERS
·
Aug 11

Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

Vera Therapeutics Grants Inducement Equity Awards to New Chief Regulatory Officer, Hires

Reuters
·
Aug 08

Vera Therapeutics Names Nancy Lee Boman as Chief Regulatory Officer in Initial Beneficial Ownership Filing

Reuters
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Vera Therapeutics (VERA)

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Vera Therapeutics (VERA) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 13